Skip to main content
. 2017 Jul 14;28(10):2526–2532. doi: 10.1093/annonc/mdx344

Figure 1.

Figure 1.

Figure 1.

PFS (A) and OS (B) according to biomarker-defined subgroups. *Based on central test results; includes tumors from all subsites (oropharyngeal and non-oropharyngeal). CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival.